Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab

JAAD Int. 2023 Mar 29:11:209-210. doi: 10.1016/j.jdin.2023.03.004. eCollection 2023 Jun.

¹ Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia.

No abstract available

Keywords: adalimumab; biologic longevity; biologics; hidradenitis suppurativa; hidradenitis suppurativa management; real-world effectiveness.